327 filings
Page 9 of 17
8-K
6bzt4ekk
7 May 15
ZIOPHARM Reports First-Quarter 2015 Financial Results and Recent Activities
12:00am
8-K
3kk rluwteutktsr
7 May 15
Departure of Directors or Certain Officers
12:00am
8-K
9sgmeu7j0
27 Apr 15
ZIOPHARM Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12
12:00am
8-K
85rizjk1 8kd7p
2 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
orpb9qacunhj5g0 3v
1 Apr 15
Other Events
12:00am
8-K
m31ypbp
30 Mar 15
ZIOPHARM-Intrexon Synthetic Immuno-Oncology Programs Strengthened through Collaboration with Merck Serono
12:00am
8-K
lfhh1jhcv
26 Feb 15
ZIOPHARM Reports Fourth-Quarter and Full-Year 2014 Financial Results and Recent Activities
12:00am
8-K
ymtrvkgld
12 Feb 15
ZIOPHARM Oncology Announces Exercise of Option to Purchase Additional Shares
12:00am
8-K
bit9tspmqjin2hj8e
4 Feb 15
ZIOPHARM Oncology Announces Pricing of Public Offering of Common Stock
12:00am
8-K
xalk2qlid4o 283l9x
4 Feb 15
Entry into a Material Definitive Agreement
12:00am
8-K
zf1iep83ux 596lc
2 Feb 15
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
12:00am
8-K/A
o9fu7 2mviz3
28 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
tresmdva1oh u8
14 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
7kve0ub6h bjgj1
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
7rvrvj5p1k
3 Dec 14
ZIOPHARM and Intrexon Present Clinical and Preclinical Data from Immuno-Oncology Programs at AACR Tumor Immunology and Immunotherapy Meeting
12:00am
8-K
ioss1
30 Oct 14
ZIOPHARM Reports Third-Quarter 2014 Financial Results
12:00am
8-K
wfck51s
16 Sep 14
Unregistered Sales of Equity Securities
12:00am
8-K
ick3f2nz96r6nz5fu
7 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
ygdmjxh bj
31 Jul 14
ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin
12:00am
8-K
6l4 1ovqgf
19 Jun 14
Departure of Directors or Certain Officers
12:00am